\-\ Texto\\:\\ \ \(0\)\
\-\ l\\-sided\\ weakness\ \(0\)\
\-\ treat\\ seizures\\.\\ surgical\\ excision\\ of\\ affected\\ lobes\\ may\\ be\\ required\\ in\\ refractory\\ cases\\.\ \(0\)\
\-\ head\\ ct\\ and\\ brain\\ mr\\ images\\ reveal\\ gyriform\\ calcification\\ over\\ the\\ right\\ cerebral\\ cortex\\.\\ \\ mr\\ findings\\ demonstrate\\ gyriform\\ signal\\ loss\\ suggestive\\ of\\ calcification\\ in\\ association\\ with\\ leptomeningeal\\ enhancement\\ and\\ ipsilateral\\ choroid\\ plexus\\ enlargement\\.\ \(0\)\
\-\ sturge\\ weber\\ syndrome\ \(0\)\
\-\ \\â\\€\\¢\\ sturge\\-weber\\ syndrome\ \(0\)\
\-\ \\â\\€\\¢\\ meningitis\\/meningoencephalitis\ \(0\)\
\-\ \\â\\€\\¢\\ torch\\ infection\\ \\(e\\.g\\.\\ herpes\\ hsv2\\)\ \(0\)\
\-\ \\â\\€\\¢\\ treated\\ brain\\ tumor\ \(0\)\
\-\ \\â\\€\\¢\\ meningioangiomatosis\\ \\(nf2\\)\ \(0\)\
\-\ \\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\ \(7\)\
\-\ \\â\\€\\¢\\ dyke\\-davidoff\\-masson\\ syndrome\\ \\(perinatal\\ carotid\\ artery\\ occlusion\\)\ \(0\)\
\-\ 17\\-year\\-old\\ boy\\ with\\ seizure\\ disorder\\.\ \(1\)\
\-\ sturge\\ weber\\ syndrome\\ \\(aka\\ encephalotrigeminal\\ angiomatosisis\\)\\ one\\ the\\ phakomatoses\\ with\\ skin\\,\\ cns\\,\\ and\\ ocular\\ involvement\\.\\ \\ \ \(0\)\
\-\ the\\ classic\\ clinical\\ symptoms\\ include\\ seizures\\ \\(90\\%\\)\\,\\ contralateral\\ hemiparesis\\ \\(30\\%\\-66\\%\\)\\,\\ hemisensory\\ defect\\,\\ and\\ developmental\\ delay\\ \\(\\>40\\%\\ if\\ seizures\\ present\\)\\;\\ association\\ with\\ subarachnoid\\ hemorrhage\\ is\\ rare\\.\\ \\ \\ a\\ facial\\ nevus\\ \\(\\"port\\-wine\\ stain\\"\\)\\ can\\ be\\ seen\\ with\\ v1\\/v2\\ distribution\\ and\\ is\\ present\\ at\\ birth\\.\\ homonymous\\ hemianopsia\\ seen\\ in\\ 2\\%\\.\ \(0\)\
\-\ classic\\ imaging\\ findings\\ can\\ include\\ cortical\\ calcifications\\ \\(\\â\\€\\œtram\\ track\\â\\€\\\\)\\,\\ ipsilateral\\ hemiatrophy\\ with\\ cortical\\ and\\ white\\ matter\\ gliosis\\,\\ leptomeningeal\\ angiomatosis\\ \\(ipsilateral\\ in\\ 80\\%\\)\\,\\ and\\ an\\ enlarged\\ enhancing\\ ipsilateral\\ choroid\\ plexus\\.\\ \\ ipsilateral\\ cerebral\\ atrophy\\ with\\ \\"gyriform\\"\\ cortical\\ calcification\\ usually\\ worsens\\ as\\ the\\ disease\\ progresses\\.\\ choroidal\\ angiomas\\ present\\ in\\ 70\\%\\ of\\ cases\\.\ \(0\)\
\-\ this\\ disorder\\ is\\ thought\\ to\\ result\\ from\\ a\\ defect\\ in\\ neural\\ crest\\ precursor\\ cells\\ which\\ result\\ in\\ abnormal\\ venous\\ drainage\\ in\\ the\\ meninges\\,\\ globe\\,\\ and\\ dermis\\.\ \(0\)\
\-\ typically\\ the\\ occipital\\ lobes\\ are\\ affected\\ first\\,\\ and\\ most\\ severely\\;\\ however\\,\\ the\\ disease\\ may\\ also\\ involve\\ the\\ parietal\\ and\\ temporal\\ lobes\\,\\ and\\ the\\ frontal\\ lobes\\.\\ midbrain\\ and\\ cerebellum\\ are\\ rarely\\ involved\\.\ \(0\)\
\-\ associated\\ disorders\\ include\\ klippel\\-trenaunay\\-weber\\ syndrome\\ and\\ neuronal\\ migration\\ anomalies\\ \\(polymicrogryia\\,\\ pachygyria\\,\\ and\\ lissencephaly\\)\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\-\\-\\:\\ 0\\.1799504548192433\ \(0\)\
\-\ ipsilateral\\:\\ 0\\.0705400877629781\ \(0\)\
\-\ gyriform\\:\\ 0\\.06386152489552958\ \(0\)\
\-\ lobes\\:\\ 0\\.043159454632859154\ \(0\)\
\-\ \\%\\:\\ 0\\.039980651098630526\ \(0\)\
\-\ sturge\\:\\ 0\\.037927185367508755\ \(0\)\
\-\ syndrome\\:\\ 0\\.03501298820536736\ \(0\)\
\-\ weber\\:\\ 0\\.034629969637402384\ \(0\)\
\-\ seizures\\:\\ 0\\.03158041433350004\ \(0\)\
\-\ leptomeningeal\\:\\ 0\\.029099420089874668\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.026940074812536755\ \(0\)\
\-\ cortical\\:\\ 0\\.026777147712686064\ \(0\)\
\-\ calcification\\:\\ 0\\.02666291362570598\ \(0\)\
\-\ dyke\\-davidoff\\-masson\\:\\ 0\\.025259365111651857\ \(0\)\
\-\ angiomatosisis\\:\\ 0\\.025259365111651857\ \(0\)\
\-\ \\-66\\:\\ 0\\.025259365111651857\ \(0\)\
\-\ polymicrogryia\\:\\ 0\\.025259365111651857\ \(0\)\
\-\ choroid\\:\\ 0\\.024992384686034326\ \(0\)\
\-\ association\\:\\ 0\\.023794150887417945\ \(0\)\
\-\ plexus\\:\\ 0\\.023794150887417945\ \(0\)\
\-\ l\\-sided\\:\\ 0\\.02327327003841419\ \(0\)\
\-\ meningitis\\/meningoencephalitis\\:\\ 0\\.02327327003841419\ \(0\)\
\-\ meningioangiomatosis\\:\\ 0\\.02327327003841419\ \(0\)\
\-\ encephalotrigeminal\\:\\ 0\\.02327327003841419\ \(0\)\
\-\ \\(\\:\\ 0\\.02276784810510735\ \(0\)\
\-\ \\)\\:\\ 0\\.022489726685519643\ \(0\)\
\-\ hsv2\\:\\ 0\\.022111478897703117\ \(0\)\
\-\ 17\\-year\\-old\\:\\ 0\\.022111478897703117\ \(0\)\
\-\ hemisensory\\:\\ 0\\.022111478897703117\ \(0\)\
\-\ port\\-wine\\:\\ 0\\.022111478897703117\ \(0\)\
\-\ v1\\/v2\\:\\ 0\\.022111478897703117\ \(0\)\
\-\ hemiatrophy\\:\\ 0\\.022111478897703117\ \(0\)\
\-\ disorder\\:\\ 0\\.021998766083357726\ \(0\)\
\-\ klippel\\-trenaunay\\-weber\\:\\ 0\\.021287174965176524\ \(0\)\
\-\ affected\\:\\ 0\\.02118925278825068\ \(0\)\
\-\ phakomatoses\\:\\ 0\\.020647795161983947\ \(0\)\
\-\ include\\:\\ 0\\.0206059039085698\ \(0\)\
\-\ perinatal\\:\\ 0\\.02012538382446545\ \(0\)\
\-\ nf2\\:\\ 0\\.019683691332123738\ \(0\)\
\-\ tram\\:\\ 0\\.019683691332123738\ \(0\)\
\-\ precursor\\:\\ 0\\.019683691332123738\ \(0\)\
\-\ sturge\\-weber\\:\\ 0\\.01930107989193886\ \(0\)\
\-\ angiomatosis\\:\\ 0\\.01930107989193886\ \(0\)\
\-\ lissencephaly\\:\\ 0\\.01930107989193886\ \(0\)\
\-\ homonymous\\:\\ 0\\.018963592683754377\ \(0\)\
\-\ result\\:\\ 0\\.01878615562720895\ \(0\)\
\-\ classic\\:\\ 0\\.018763638273971758\ \(0\)\
\-\ worsens\\:\\ 0\\.01838860501767372\ \(0\)\
\-\ angiomas\\:\\ 0\\.01838860501767372\ \(0\)\
\-\ defect\\:\\ 0\\.018330930236675796\ \(0\)\
\-\ pachygyria\\:\\ 0\\.018139288751227785\ \(0\)\
\-\ crest\\:\\ 0\\.017499908948035207\ \(0\)\
\-\ torch\\:\\ 0\\.017314984818701192\ \(0\)\
\-\ aka\\:\\ 0\\.017314984818701192\ \(0\)\
\-\ neuronal\\:\\ 0\\.017314984818701192\ \(0\)\
\-\ gliosis\\:\\ 0\\.017141275300602526\ \(0\)\
\-\ choroidal\\:\\ 0\\.017141275300602526\ \(0\)\
\-\ meninges\\:\\ 0\\.017141275300602526\ \(0\)\
\-\ cerebral\\:\\ 0\\.01696530946569668\ \(0\)\
\-\ nevus\\:\\ 0\\.016822577205730826\ \(0\)\
\-\ present\\:\\ 0\\.016590333128352557\ \(0\)\
\-\ hemianopsia\\:\\ 0\\.016402509944436053\ \(0\)\
\-\ progresses\\:\\ 0\\.016402509944436053\ \(0\)\
\-\ cases\\:\\ 0\\.016314102372384714\ \(0\)\
\-\ track\\:\\ 0\\.016036225212316037\ \(0\)\
\-\ herpes\\:\\ 0\\.01581570646980564\ \(0\)\
\-\ dermis\\:\\ 0\\.015711501185648406\ \(0\)\
\-\ mr\\:\\ 0\\.01555988236072455\ \(0\)\
\-\ midbrain\\:\\ 0\\.015419860227740263\ \(0\)\
\-\ hemiparesis\\:\\ 0\\.01524071880372498\ \(0\)\
\-\ refractory\\:\\ 0\\.015155180227364862\ \(0\)\
\-\ stain\\:\\ 0\\.015072121382455828\ \(0\)\
\-\ severely\\:\\ 0\\.014912895447914824\ \(0\)\
\-\ ocular\\:\\ 0\\.014836482132493159\ \(0\)\
\-\ brain\\:\\ 0\\.014735538815488607\ \(0\)\
\-\ migration\\:\\ 0\\.01448228741625483\ \(0\)\
\-\ globe\\:\\ 0\\.01422742355947404\ \(0\)\
\-\ treat\\:\\ 0\\.013829611396567977\ \(0\)\
\-\ contralateral\\:\\ 0\\.013527718801559879\ \(0\)\
\-\ e\\.g\\:\\ 0\\.012965785051054748\ \(0\)\
\-\ anomalies\\:\\ 0\\.012812931238145598\ \(0\)\
\-\ atrophy\\:\\ 0\\.012632662397427635\ \(0\)\
\-\ cns\\:\\ 0\\.012529705350934617\ \(0\)\
\-\ neural\\:\\ 0\\.01239794284880905\ \(0\)\
\-\ occlusion\\:\\ 0\\.012211007256062915\ \(0\)\
\-\ cerebellum\\:\\ 0\\.012181003531514792\ \(0\)\
\-\ delay\\:\\ 0\\.012151310731986003\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.012035157808778322\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.011897075443708972\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.011803722074396807\ \(0\)\
\-\ birth\\:\\ 0\\.011765009233966086\ \(0\)\
\-\ 70\\:\\ 0\\.011765009233966086\ \(0\)\
\-\ rarely\\:\\ 0\\.011739311039173075\ \(0\)\
\-\ disorders\\:\\ 0\\.011713841275799879\ \(0\)\
\-\ \\,\\:\\ 0\\.011635103102462208\ \(0\)\
\-\ \\;\\:\\ 0\\.011606998214628043\ \(0\)\
\-\ 90\\:\\ 0\\.011541623728322212\ \(0\)\
\-\ involve\\:\\ 0\\.011541623728322212\ \(0\)\
\-\ 80\\:\\ 0\\.011517844923695578\ \(0\)\
\-\ occipital\\:\\ 0\\.01142465526264813\ \(0\)\
\-\ developmental\\:\\ 0\\.01137917288684214\ \(0\)\
\-\ thought\\:\\ 0\\.011268528657249649\ \(0\)\
\-\ can\\:\\ 0\\.011107291418160857\ \(0\)\
\-\ distribution\\:\\ 0\\.011019212390803718\ \(0\)\
\-\ carotid\\:\\ 0\\.010979689977817083\ \(0\)\
\-\ reveal\\:\\ 0\\.010902243925129633\ \(0\)\
\-\ seizure\\:\\ 0\\.010826836164907934\ \(0\)\
\-\ may\\:\\ 0\\.01074113678451647\ \(0\)\
\-\ facial\\:\\ 0\\.01064656732418997\ \(0\)\
\-\ cortex\\:\\ 0\\.01047697170416037\ \(0\)\
\-\ suggestive\\:\\ 0\\.01046055143278792\ \(0\)\
\-\ parietal\\:\\ 0\\.01046055143278792\ \(0\)\
\-\ findings\\:\\ 0\\.010423134302521259\ \(0\)\
\-\ 40\\:\\ 0\\.010301325498246914\ \(0\)\
\-\ involved\\:\\ 0\\.010270515206624389\ \(0\)\
\-\ drainage\\:\\ 0\\.010240032690277524\ \(0\)\
\-\ excision\\:\\ 0\\.010049429015946399\ \(0\)\
\-\ cells\\:\\ 0\\.00981789883710601\ \(0\)\
\-\ temporal\\:\\ 0\\.009804844921530477\ \(0\)\
\-\ enlargement\\:\\ 0\\.009715095720587666\ \(0\)\
\-\ seen\\:\\ 0\\.009676949083482465\ \(0\)\
\-\ in\\:\\ 0\\.009659535361381201\ \(0\)\
\-\ matter\\:\\ 0\\.00964034375473008\ \(0\)\
\-\ rare\\:\\ 0\\.009508166758376206\ \(0\)\
\-\ 30\\:\\ 0\\.009415728757750931\ \(0\)\
\-\ skin\\:\\ 0\\.009404380903263548\ \(0\)\
\-\ \\â\\€\\œ\\:\\ 0\\.009144701770140859\ \(0\)\
\-\ calcifications\\:\\ 0\\.009103621073446281\ \(0\)\
\-\ weakness\\:\\ 0\\.009093442272287634\ \(0\)\
\-\ \\â\\€\\\\:\\ 0\\.009093442272287634\ \(0\)\
\-\ involvement\\:\\ 0\\.008974036265409217\ \(0\)\
\-\ venous\\:\\ 0\\.008887637875235327\ \(0\)\
\-\ required\\:\\ 0\\.008812967082484996\ \(0\)\
\-\ typically\\:\\ 0\\.008643053780819403\ \(0\)\
\-\ enlarged\\:\\ 0\\.008354215101386838\ \(0\)\
\-\ boy\\:\\ 0\\.008322985042767825\ \(0\)\
\-\ first\\:\\ 0\\.00821628491342651\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.008149732332882624\ \(0\)\
\-\ \\>\\:\\ 0\\.008135150471829698\ \(0\)\
\-\ white\\:\\ 0\\.00812064244330091\ \(0\)\
\-\ disease\\:\\ 0\\.008004226597224665\ \(0\)\
\-\ frontal\\:\\ 0\\.007691380901098445\ \(0\)\
\-\ enhancing\\:\\ 0\\.007678949950959195\ \(0\)\
\-\ be\\:\\ 0\\.007551614460423663\ \(0\)\
\-\ clinical\\:\\ 0\\.007533838968670499\ \(0\)\
\-\ usually\\:\\ 0\\.007435324509646874\ \(0\)\
\-\ treated\\:\\ 0\\.007329085490211631\ \(0\)\
\-\ artery\\:\\ 0\\.007290916882831515\ \(0\)\
\-\ and\\:\\ 0\\.0072209916339571875\ \(0\)\
\-\ infection\\:\\ 0\\.007117526000208616\ \(0\)\
\-\ loss\\:\\ 0\\.00710734719904997\ \(0\)\
\-\ abnormal\\:\\ 0\\.00698307232181923\ \(0\)\
\-\ head\\:\\ 0\\.00694441636267592\ \(0\)\
\-\ however\\:\\ 0\\.006817673511739457\ \(0\)\
\-\ are\\:\\ 0\\.006675494971516342\ \(0\)\
\-\ if\\:\\ 0\\.006643963993640789\ \(0\)\
\-\ one\\:\\ 0\\.006635333476534797\ \(0\)\
\-\ enhancement\\:\\ 0\\.006563005060524458\ \(0\)\
\-\ signal\\:\\ 0\\.006455800373274438\ \(0\)\
\-\ over\\:\\ 0\\.006233932923037142\ \(0\)\
\-\ symptoms\\:\\ 0\\.0061021704209115735\ \(0\)\
\-\ associated\\:\\ 0\\.005777829690279948\ \(0\)\
\-\ imaging\\:\\ 0\\.005736601216205165\ \(0\)\
\-\ tumor\\:\\ 0\\.005708402010346164\ \(0\)\
\-\ most\\:\\ 0\\.005652822755667839\ \(0\)\
\-\ demonstrate\\:\\ 0\\.005634533356255131\ \(0\)\
\-\ 2\\:\\ 0\\.0052725057206605905\ \(0\)\
\-\ \\-\\:\\ 0\\.005248505612344881\ \(0\)\
\-\ surgical\\:\\ 0\\.005146767250004165\ \(0\)\
\-\ is\\:\\ 0\\.004833445086401653\ \(0\)\
\-\ also\\:\\ 0\\.004826990239742554\ \(0\)\
\-\ images\\:\\ 0\\.004697031209023937\ \(0\)\
\-\ which\\:\\ 0\\.004570614863159165\ \(0\)\
\-\ as\\:\\ 0\\.00370366047534134\ \(0\)\
\-\ from\\:\\ 0\\.0036287556250837027\ \(0\)\
\-\ the\\:\\ 0\\.003565167800380035\ \(0\)\
\-\ ct\\:\\ 0\\.0034249388349342205\ \(0\)\
\-\ an\\:\\ 0\\.003385859209984899\ \(0\)\
\-\ at\\:\\ 0\\.0033173729307496647\ \(0\)\
\-\ this\\:\\ 0\\.002753974823249665\ \(0\)\
\-\ right\\:\\ 0\\.0025834719458751195\ \(0\)\
\-\ with\\:\\ 0\\.002346788632175439\ \(0\)\
\-\ a\\:\\ 0\\.0022727782339174857\ \(0\)\
\-\ \\.\\:\\ 0\\.0017292037640541165\ \(0\)\
\-\ to\\:\\ 0\\.0012236908551374963\ \(0\)\
\-\ of\\:\\ 0\\.0010014653363723935\ \(0\)\
